Structure to function: muscle failure in critically ill patients

Impaired physical function and reduced physical activity are common findings in intensive care unit (ICU) survivors. More importantly, reduced muscle strength during critical illness is an independent predictor of survival. Skeletal muscle wasting as a direct consequence of critical illness has been suggested as the cause. However, data on the physiological processes regulating muscle mass, and function, in these critically ill patients are limited as this is not only a technically challenging research area, but also the heterogeneity of the patient group adds complexity to the interpretation of results. Despite this, clinical and research interest in this area is growing. This article highlights the issues involved in measurement of muscle function and mass in critically ill patients and the physiological complexities involved in studying these patients. Although the data are limited, this article reviews the animal and healthy human data providing a rational approach to the potential pathophysiological mechanisms involved in muscle mass regulation in critically ill patients, including the established muscle wasting ‘risk factors’ such as ageing, immobility and systemic inflammation, all of which are common findings in the general critical care population.

[1]  J. Laffey,et al.  Casual bystander or active participant? New clues about adiponectin and traumatic injury. , 2011, Critical care medicine.

[2]  G. Harlow,et al.  A Protocol of No Sedation for Critically Ill Patients Receiving Mechanical Ventilation: A Randomised Trial , 2011 .

[3]  H. Crossland,et al.  Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle , 2010, The Journal of physiology.

[4]  J. Vincent,et al.  Clinical review: Scoring systems in the critically ill , 2010, Critical care.

[5]  Torben Martinussen,et al.  A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial , 2010, The Lancet.

[6]  J. Wernerman,et al.  Protein metabolism in leg muscle following an endotoxin injection in healthy volunteers. , 2009, Clinical science.

[7]  R. Stevens,et al.  Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality* , 2009, Critical care medicine.

[8]  Christina Routsi,et al.  Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study , 2009, Critical care.

[9]  M. Rennie Anabolic resistance in critically ill patients , 2009, Critical care medicine.

[10]  R. Griffiths,et al.  Exploring intensive care unit-acquired weakness. Preface. , 2009, Critical care medicine.

[11]  D. Constantin-Teodosiu,et al.  Effects of Endotoxaemia on Protein Metabolism in Rat Fast-Twitch Skeletal Muscle and Myocardium , 2009, PloS one.

[12]  Arnaud Capri,et al.  Quantification of muscle volume by echography: comparison with MRI data on subjects in long-term bed rest. , 2009, Ultrasound in medicine & biology.

[13]  A. Russell,et al.  Atrogin‐1, MuRF1, and FoXO, as well as phosphorylated GSK‐3β and 4E‐BP1 are reduced in skeletal muscle of chronic spinal cord–injured patients , 2009, Muscle & nerve.

[14]  M. Tarnopolsky,et al.  Differential stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at rest and after resistance exercise , 2009, The Journal of physiology.

[15]  J Moxham,et al.  Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD , 2009, Thorax.

[16]  M. Rennie,et al.  Age‐related differences in the dose–response relationship of muscle protein synthesis to resistance exercise in young and old men , 2009, The Journal of physiology.

[17]  P. Greenhaff,et al.  The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. , 2008, Biochimica et biophysica acta.

[18]  M. Tarnopolsky,et al.  Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion , 2008, The Journal of physiology.

[19]  J. Timmons,et al.  Dysregulation of Mitochondrial Dynamics and the Muscle Transcriptome in ICU Patients Suffering from Sepsis Induced Multiple Organ Failure , 2008, PloS one.

[20]  H. Crossland,et al.  A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle , 2008, The Journal of physiology.

[21]  R. Wolfe,et al.  Functional impact of 10 days of bed rest in healthy older adults. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  S. Bodine,et al.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. , 2008, American journal of physiology. Endocrinology and metabolism.

[23]  S. Lemeshow,et al.  Acquired weakness, handgrip strength, and mortality in critically ill patients. , 2008, American journal of respiratory and critical care medicine.

[24]  M. Rennie,et al.  Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle , 2008, American journal of physiology. Endocrinology and metabolism.

[25]  M. Rennie,et al.  Differences in Muscle Protein Synthesis and Anabolic Signaling in the Postabsorptive State and in Response to Food in 65–80 Year Old Men and Women , 2008, PloS one.

[26]  F. Kainberger,et al.  Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle layer. , 2008, Journal of rehabilitation medicine.

[27]  Eberhard Schulz,et al.  Physical Inactivity Rapidly Induces Insulin Resistance and Microvascular Dysfunction in Healthy Volunteers , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[28]  C. Maganaris,et al.  The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse , 2007, The Journal of physiology.

[29]  M. Polkey,et al.  A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. , 2007, Journal of applied physiology.

[30]  B. de Jonghe,et al.  Respiratory weakness is associated with limb weakness and delayed weaning in critical illness* , 2007, Critical care medicine.

[31]  A. Russell,et al.  Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[32]  B. Ahlman,et al.  Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. , 2007, Clinical science.

[33]  A. Goldberg,et al.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[35]  Arthur S Slutsky,et al.  Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. , 2006, American journal of respiratory and critical care medicine.

[36]  C. Pichard,et al.  A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. , 2006, Clinical nutrition.

[37]  A. Russell,et al.  Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Kandarian,et al.  Intracellular signaling during skeletal muscle atrophy , 2006, Muscle & nerve.

[39]  J. Wernerman,et al.  Amino acid metabolism in leg muscle after an endotoxin injection in healthy volunteers. , 2005, American journal of physiology. Endocrinology and metabolism.

[40]  W. Frontera,et al.  IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.

[41]  S. Kandarian,et al.  The molecular basis of skeletal muscle atrophy. , 2004, American journal of physiology. Cell physiology.

[42]  Simon W. Jones,et al.  Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[44]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  R. Wolfe,et al.  Human Muscle Protein Synthesis is Modulated by Extracellular, Not Intramuscular Amino Acid Availability: A Dose‐Response Study , 2003, The Journal of physiology.

[46]  E. Wouters,et al.  Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[47]  P. Vondracek,et al.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity , 2003, Intensive Care Medicine.

[48]  Arthur S Slutsky,et al.  One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.

[49]  Isabelle Durand-Zaleski,et al.  Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.

[50]  G. Biolo,et al.  Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. , 2002, The Journal of clinical endocrinology and metabolism.

[51]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[52]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[53]  R. Wolfe,et al.  Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. , 2001, JAMA.

[54]  J. Moxham,et al.  Measurement of twitch transdiaphragmatic, esophageal, and endotracheal tube pressure with bilateral anterolateral magnetic phrenic nerve stimulation in patients in the intensive care unit , 2001, Critical care medicine.

[55]  R. Roine,et al.  Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis , 2000, Intensive Care Medicine.

[56]  M. Polkey,et al.  Adductor pollicis twitch tension assessed by magnetic stimulation of the ulnar nerve. , 2000, American journal of respiratory and critical care medicine.

[57]  Griffiths,et al.  Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin , 1998, Neuropathology and applied neurobiology.

[58]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.

[59]  K. Andersson,et al.  Longitudinal changes of biochemical parameters in muscle during critical illness. , 1997, Metabolism: clinical and experimental.

[60]  T. Meyer,et al.  Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. , 1997, The Journal of clinical investigation.

[61]  A. Kari,et al.  Five-year survival after intensive care-comparison of 12,180 patients with the general population , 1996 .

[62]  P. Essén,et al.  Protein synthesis rates of skeletal muscle, lymphocytes, and albumin with stress hormone infusion in healthy man. , 1996, Metabolism: clinical and experimental.

[63]  A. Vuagnat,et al.  Long-term outcome and quality of life of patients requiring multidisciplinary intensive care unit admission after cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.

[64]  J. Willeit,et al.  Polyneuropathies in critically ill patients: A prospective evaluation , 1996, Intensive Care Medicine.

[65]  D. Recupero,et al.  Critical illness myopathy and neuropathy , 1996, The Lancet.

[66]  D. Breuillé,et al.  Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. , 1996, The Journal of clinical investigation.

[67]  P. Essén,et al.  A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. , 1996, Critical care medicine.

[68]  R. Wolfe,et al.  Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. , 1996, The American journal of physiology.

[69]  E. Barrett,et al.  Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. , 1995, The Journal of clinical investigation.

[70]  I. Campbell,et al.  Muscle thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple organ failure in the presence of edema. , 1995, The American journal of clinical nutrition.

[71]  M. Polkey,et al.  Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man , 1995, Muscle & nerve.

[72]  J. Wernerman,et al.  Stress hormone and amino acid infusion in healthy volunteers: short-term effects on protein synthesis and amino acid metabolism in skeletal muscle. , 1994, Metabolism: clinical and experimental.

[73]  D. Häussinger,et al.  Cellular hydration state: an important determinant of protein catabolism in health and disease , 1993, The Lancet.

[74]  E. Barrett,et al.  Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. , 1992, The Journal of clinical investigation.

[75]  R. Lenkinski,et al.  Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure , 1992, Circulation.

[76]  P. Schmitz,et al.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.

[77]  C. Scrimgeour,et al.  Muscle protein synthesis in patients with rheumatoid arthritis: effect of chronic corticosteroid therapy on prostaglandin F2α availability , 1991, European journal of clinical investigation.

[78]  E. Hultman,et al.  Muscle composition in relation to age and sex. , 1991, Clinical science.

[79]  E. Hultman,et al.  Muscle alkali-soluble protein, carnitine, water and electrolytes in patients with persistent post-operative infection. , 1989, Clinical nutrition.

[80]  K. Hainaut,et al.  Electrical and mechanical changes in immobilized human muscle. , 1987, Journal of applied physiology.

[81]  M. Rennie,et al.  Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. , 1987, Clinical science.

[82]  W. Sibbald,et al.  Polyneuropathy in critically ill patients , 1984, Journal of Neurology, Neurosurgery & Psychiatry.

[83]  D. Jones,et al.  Human skeletal muscle function: description of tests and normal values. , 1977, Clinical science and molecular medicine.

[84]  R. Tomanek,et al.  Degeneration of different types of skeletal muscle fibres. II. Immobilization. , 1974, Journal of anatomy.

[85]  D. J. Millward,et al.  Protein turnover in cardiac and skeletal muscle. , 1973, The Journal of physiology.

[86]  J. Barker,et al.  Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial , 2010 .

[87]  F. Trensz,et al.  Regulation of Protein Metabolism in Exercise and Recovery A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse , 2009 .

[88]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.

[89]  M. Polkey,et al.  Ultrasound Measurement of Rectus Femoris Cross-Sectional Area and the Relationship to Quadriceps Strength in Chronic Obstructive Pulmonary Disease Running Head: Quadriceps Ultrasound in COPD , 2009 .

[90]  R. Wolfe,et al.  Stimulation of net muscle protein synthesis by whey protein ingestion before and after exercise. , 2007, American journal of physiology. Endocrinology and metabolism.

[91]  M. Honavar,et al.  Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis , 2005, Intensive Care Medicine.

[92]  A. Gimson,et al.  Hepatic dysfunction during bacterial sepsis , 2004, Intensive Care Medicine.

[93]  R. Wolfe,et al.  Acute response of net muscle protein balance reflects 24-h balance after exercise and amino acid ingestion. , 2003, American journal of physiology. Endocrinology and metabolism.

[94]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[95]  P. Essén,et al.  Tissue protein synthesis rates in critically ill patients. , 1998, Critical care medicine.

[96]  A. Kari,et al.  Five-year survival after intensive care--comparison of 12,180 patients with the general population. Finnish ICU Study Group. , 1996, Critical care medicine.

[97]  D. Wilmore,et al.  Growth hormone attenuates the abnormal distribution of body water in critically ill surgical patients. , 1992, Surgery.

[98]  M. Rennie,et al.  Muscle protein turnover and the wasting due to injury and disease. , 1985, British medical bulletin.